FGF9 and hepatocellular carcinoma: Figures 3E, F showed the expression levels of KIF2C, G6PD, CCNJL, CDC20, TRIP13, HAVCR1, MPP2, CEP55, IGLON5, SLC2A1, ALX1, TEX15, MSC, IGF2BP3, FGF9, OR8A1, RCOR2, PFN2, DDN, CLDN6, UGT1A10, ZNF280A, PRR20G, DNAJC5G, SLC16A3, BOLL, KRT17, DAW1, RFPL4B, RIPPLY2, UNC13C, RIMKLA, GABRA3, PLBD1, PRDM9, POU3F2, and FABP6 in HCC tissues.